Vivos Therapeutics, Inc. NASDAQ: VVOS
Vivos Therapeutics, Inc. Annual Shareholder Meeting
September 22, 2023
4:00 EST/ 2:00 MST
Download Vivos Therapeutics, Inc. 2023 Annual Report
An Important Breakthrough in the Treatment for Mild-to-Moderate Obstructive Sleep Apnea
Vivos offers a multidisciplinary treatment protocol that uses nonsurgical, noninvasive, and cost-effective oral appliance technology prescribed by trained dentists and medical professionals to treat dentofacial abnormalities and/or mild-to-moderate OSA. This revolutionary treatment is called The Vivos Method.
Latest Stock Information
Please Listen to Our Q2 2023 Financial Results Conference Call here at 6:00PM EDT Wednesday, August 16, 2023
Corporate Leadership
Our leadership team is devoted to a singular mission: to rid the world of sleep apnea.
Meet Our Leadership Team
40000
Patients Treated
1800
Doctors Integrated + Trained
1
Over 1 Billion Potential Patients
Investor Relations Contacts
Home Office
Vivos Therapeutics, Inc.
(866) 908-4867
7921 Southpark Plaza
Suite 210
Littleton, CO
80120
Investor Relations
Julie Gannon
Investment Relations Officer
(720) 442-8113
7921 Southpark Plaza
Suite 210
Littleton, CO
80120
Email:jgannon@vivoslife.com
Phil Carlson / Scott Eckstein
KCSA Strategic Communications
(212) 896-1210
Vivos@kcsa.com
Transfer Agent
Vstock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: (212) 828-8436
Fax: (646) 536-3179
info@vstocktransfer.com
